Luteolin suppresses IL-1β-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982

Food and Chemical Toxicology

Volumn 48, Issue 10, 2010, Pages 2607-2611

  Choi, Eun Mi ^a   Lee, Young Soon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Cytokines; Luteolin; Matrix metalloproteinases; Mitogen activated protein kinases; Synoviocyte; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

CELL LINE, TUMOR; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUTEOLIN; MATRIX METALLOPROTEINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SARCOMA; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR AP-1;

EID: 77956338212     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.06.029     Document Type: Article

References (39)

1. Barchowsky A., Frleta D., Vincentt M.P. Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 2000, 12:1469-1479.
2. Berk B.C., Abe J.I., Min W., Surapisitchat J., Yan C. Endothelial atheroprotective and anti-inflammatory mechanisms. Ann. NY. Acad. Sci. 2001, 947:93-109.
3. Bondeson J., Foxwell B., Brennan F., Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammtory mediators. Proc. Natl. Acad. Sci. USA 1999, 96:5668-5673.
4. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 2003, 253:269-285.
5. Eldridge A.L., Haytowitz D.B., Bhagwat S., Gebhardt S.E., Holden J.M., Beecher G.R., Peterson J., Dwyer J. Flavonoid Content of Vegetables: The USDA's Flavonoid Database 2003, Human Nutrition Research Center, ARS, USDA.
6. Firestein G.S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum 1996, 39:1781-1790.
7. Garcia-Vicuna R., Gomez-Gaviro M.V., Dominguez-Luis M.J., Pec M.K., Gonzalez-Alvaro I., Alvaro-Gracia J.M. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes form rheumatoid arthritis patients. Arthritis Rheum. 2004, 50:3866-3877.
8. Garrington T.P., Johnston G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 1999, 11:211-218.
9. Hammaker D., Sweeney S., Firestein G.S. Signal transduction networks in rheumatoid arthritis. Ann. Rheum. Dis. 2003, 62:86-89.
10. Han Z., Boyle D.L., Aupperle K.R., Bennett B., Manning A.M., Firestein G.S. Jun N-terminal kinase in rheumatoid arthritis. J. Pharmacol. Exp. Ther. 1999, 291:124-130.
11. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., Firestein G.S. C-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 2001, 108:73-81.
12. Hou Y., Wu J., Huang Q., Guo L. Luteolin inhibits proliferation and affects the function of stimulated rat synovial fibroblasts. Cell Biol. Int. 2009, 33:135-147.
13. Husain S.R., Cillard J., Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 1987, 26:2489-2492.
14. Jue D.M., Jeon K.I., Jeong J.Y. Nuclear factor kappaB(NF-κB) pathway as a therapeutic target in rheumatoid arthritis. J. Korean Med. Sci. 1999, 14:231-238.
15. Konttinen Y.T., Ainola M., Valleala H. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 1999, 58:691-697.
16. Lipsky P.E. Rheumatoid arthritis. Harrisons principles of internal medicine 1994, 1648-1655. McGraw Hill, New York. K.J. Issel bacher (Ed.).
17. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinkerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB. Arthritis Rheum. 2000, 43:801-811.
18. Miagkov A.V., Kovalenko D.V., Brown C.E., Didsbury J.R., Cogswell J.P., Stimpson S.A., Baldwin A.S., Makarov S.S. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acd. Sci. USA 1998, 95:13859-13864.
19. Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., Okudaira H. Regulation of interleukin-1β-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 1998, 273:24835-24838.
20. Nagao M., Morita N., Yahagi T., Shimizu M., Kuroyanagi M., Fukuoka M., Yoshihira K., Natori S., Fujino T., Sugimura T. Mutagenicities of 61 flavonoids and 11 related compounds. Environ. Mutagen 1981, 3:401-419.
21. Ono K., Han J. The p38 signal transduction pathway. Activation and function. Cell. Signal. 2000, 12:1-13.
22. Piecyk M., Anderson P. Signal transduction in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2001, 15:789-803.
23. Qiu D., Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of tripolide, the principle active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. F. Drugs R D 2003, 4:1-18.
24. Rano T. The biology of interleukin-6. Chem. Immunol. 1992, 51:153-180.
25. Sakane T., Suzuki N., Hirose Y. Mechanisms of KE298, 2-acetyl-thiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 1997, 24:2213-2220.
26. Samejima K., Kanazawa K., Ashida H., Danno G.J. Luteolin: a strong antimutagen against dietary carcinogen, Trp-P-2, in peppermint, sage, and thyme. J. Agric. Food Chem. 1995, 43:410-414.
27. Skiles J.W., Gonnella N.C., Jeng A.W. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors. Curr. Med. Chem. 2001, 8:425-474.
28. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., Berk B.C. Fluid shear stress inhibits TNF-α activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA 2001, 98:6476-6481.
29. Sweeney S.E., Firestein G.S. Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 2004, 36:372-378.
30. Tan P.L.J., Farmiloe S., Yeoman S., Watson J.D. Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J. Rheumatol. 1990, 17:1608-1612.
31. Tanaka Y. The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis. Drugs Today 2001, 37:477-484.
32. Warren J.S. Interleukins and tumor necrosis factor in inflammation. Crit. Rev. Clin. Lab. Sci. 1990, 28:37-59.
33. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
34. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 1996, 74:589-607.
35. Yamamoto H., Sakakibara J., Nagatsu A., Sekiya K. Inhibitors of arachidonate lipoxygenase from defatted perilla seed. J. Agric. Food Chem. 1998, 46:862-865.
36. Yamanishi Y., Firestein G.S. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum. Dis. Clin. North Am. 2001, 27:355-371.
37. Yamazaki T., Yokoyama T., Akitsu H., Tukiyama T., Tokiwa T. Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone. In Vitro Cell. Dev. Biol. 2003, 39:337-339.
38. Yasukawa K., Takido M., Takeuchi M., Nakagawa S. Effect of chemical constituents from plants on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Chem. Pharm. Bull. 1989, 37:1071-1073.
39. Yoshihara Y., Nakamura H., Obata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 2000, 59:455-461.